News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Wins Injunction Against Aprica Over Generic Januvia


6/25/2013 7:35:50 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MSD, a unit of U.S. drugmaker Merck & Co, said it has won an injunction against India's Aprica Pharmaceuticals and a source said this will stop Aprica launching generic versions of two diabetes drugs in India. Global pharmaceutical firms have had a series of patent disputes with Indian makers of generic drugs and several recent Indian rulings have gone against the international giants. MSD holds an Indian patent on sitagliptin, a chemical compound sold under the Januvia and Janumet brands used to treat type-2 diabetes.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES